Stories
Updates: Lilly's Global COVID-19 Response
View Story
Lilly's COVID-19 Science Leads to a Second FDA Emergency Use Authorization
View Story
When the World Called for Help with COVID-19, We Were Ready
View Story
Dave Ricks Shares About Lilly's FDA Emergency Use Authorization for a Neutralizing Antibody
View Story
CEO Dave Ricks Shares Lilly's Principles of COVID-19 Antibody Therapy Pricing and Access
View Story
Increasing Diversity in Clinical Trials
View Story
Overcoming Barriers to Biomarker Testing in Cancer
View Story
What Does It Take to Manufacture Neutralizing Antibodies?
View Story
The Power of Loxo Oncology at Lilly
View Story
Lilly Creates Mobile Research Units to Reach Elderly Patients
View Story